|Biomarker Market for Diagnostic Applications is expected to garner $30.6 Billion Globally by 2020, registering a CAGR of 16% during the forecast period 2013 to 2020.|
The demands of diagnostic markets are increasing. Where conventional diagnostic tools were focused on producing accurate and consistent results, today's market demand extend to early diagnosis with accurate and consistent results. There are significant challenges in presenting accurate results in the early stage of diseases, especially in case of cancer.
Diagnostic biomarker market is growing with development of technologies in clinical laboratory tests, imaging exams, and in recent years biomarker tests are impacting the clinical management of patients. Biomarkers are identified conventionally by analyzing the science of pathophysiology and epidemiology, which derive insensitive and nonspecific markers. +
The biomarker market in this report includes the application of biomarkers in the diagnosis (molecular diagnosis and disease diagnosis), drug validation, drug development, risk assessment, drug formulation and forensic applications. Technologies that immensely make use of biomarkers such as Omics, imaging technologies, bioinformatics and personalized medicines are also included in the study.
The report offers an assessment and ranking of the factors that favor the biomarkers market growth and those factors which act as a hindrance for the growth of the market.
Forecast period for estimating market size is from 2013 to 2020. Two historic years include 2011 and 2012.
The report identifies top investment pockets and offers an analysis of top winning strategies for diagnostic biomarker industry.
The report analyses the various strategies adopted by some of the key companies in the industry.